News: Implanting 3D Bioscaffolds in Rats Works to Trigger FVIII Production
A study shows that implanting 3D bioscaffolds in rats works to trigger FVIII production. These are 3D biological scaffolds made up of collagen and other molecules. The goal is to develop an alternative treatment option to FVIII replacement therapy, a current standard of care treatment for hemophilia A. Read the full story on our main website here.
What do you think about this study? Do you think this therapy has potential?
Sorry, there were no replies found.
Log in to reply.